Skip to main content
logo
Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.83
-0.16 (-1.60%)
Jan 28, 2026, 3:05 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
T Cell Redirecting Immunotherapies
168.57M
Log In
Log In
Log In
Log In
Upgrade
T Cell Redirecting Immunotherapies Growth
188.75%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
United States
152.39M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
151.43%
Log In
Log In
Log In
Log In
Upgrade
Denmark
16.17M
Log In
Log In
Log In
Log In
Upgrade
Denmark Growth
-823.70%
Log In
Log In
Log In
Log In
Upgrade
United Kingdom
-
Log In
Log In
Log In
Log In
Upgrade
Germany
-
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-
Log In
Log In
Log In
Log In
Upgrade